eFFECTOR Therapeutics, Inc. (EFTR) Social Stream



eFFECTOR Therapeutics, Inc. (EFTR): $14.23

0.78 (+5.80%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

C

Add EFTR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#236 of 363

in industry

EFFECTOR THERAPEUTICS INC (EFTR) Price Targets From Analysts

Use the tables below to see what analysts covering EFFECTOR THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 4 $50 $20 $30.75 $0.531 5690.96%
2022-01-25 4 $50 $6.2 $27.3 $0.531 5041.24%
2022-05-11 4 $50 $3.4 $26.6 $0.531 4909.42%
2022-08-11 4 $10 $3.4 $6.133 $0.531 1054.99%
2022-11-08 3 $10 $3 $6 $0.531 1029.94%
2022-11-17 3 $10 $2 $5 $0.531 841.62%
2023-03-09 3 $10 $1 $4.1 $0.531 672.13%
2023-05-11 4 $10 $1 $4.825 $0.531 808.66%
2023-06-05 4 $10 $1 $6.25 $0.531 1077.02%
2023-08-09 4 $10 $1 $5.85 $0.531 1001.69%
2023-08-24 4 $7 $1 $4.6 $0.531 766.29%
2023-11-13 3 $7 $5 $5.8 $0.531 992.28%

The Trend in the Analyst Price Target


Over the past 44 weeks, EFTR's average price target has gone up $1.7.

Over the past 44 weeks, EFTR's average upside potential has been 733.27%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-05-11 4 10 1 4.825 0.542 790.22%
2023-08-24 3 7 1 4.600 0.720 538.89%
2023-08-24 4 7 5 5.800 0.720 705.56%
2023-08-24 5 10 1 5.680 0.720 688.89%
2023-08-24 5 7 5 5.800 0.720 705.56%

EFTR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


EFTR's average broker recommendation rating improved by 0.67 over the prior 43 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • EFTR has a greater upside potential (average analyst target price relative to current price) than 1757.82% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, EFFECTOR THERAPEUTICS INC's variance in analysts' estimates is lower than -1563.14% of them.
  • EFFECTOR THERAPEUTICS INC's number of analysts covering the stock is higher than 262.83% of Healthcare stocks.
  • EFTR has a greater average analyst price target than 322.52% of Healthcare stocks.

In the Pharmaceutical Products industry, BOLT, TERN, and ADAG are the three stocks most similar to EFFECTOR THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding EFTR using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!